Glenview Trust’s CME Group CME Stock Holding History

Glenview Trust’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$370K	Buy	1,674 +436	+35%	+$121K	0.01%	415
2026 Q1	$366K	Buy	1,238 +294	+31%	+$87.3K	0.01%	409
2025 Q4	$258K	Buy	+944	New	+$257K	﹤0.01%	448

Other funds holding CME

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Glenview Trust's CME Position: Q2 2026 in Review

Glenview Trust increased its CME Group (CME) stake by 35% in Q2 2026, buying an estimated $121K and bringing the position to 1,674 shares worth $370K. The position accounts for 0.01% of the portfolio, ranked #415.

Glenview Trust first reported a position in CME in Q4 2025 and has held it in 3 quarters since. 1,703 funds tracked by Wall St. Rank hold CME as of Q2 2026.

Glenview Trust held 1,674 shares of CME Group worth $370K as of Q2 2026.
Glenview Trust bought 436 CME Group shares in Q2 2026, an estimated $121K.
CME Group made up 0.01% of Glenview Trust's portfolio in Q2 2026, its #415 holding.
Glenview Trust first reported a position in CME Group in Q4 2025 and has held it in 3 quarters since.
1,703 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Glenview Trust's 13F filing for Q2 2026, filed 11 Aug 2026.